CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 113 enrolled
Drug / intervention
Shortwave diathermydevice
Likely dose
Shortwave diathermy 20 minutes per session, 3 sessions per week for 3 weeksAI-extracted
Key inclusion· 2
  • ✓Peri- or postmenopausal women aged >50 years
  • ✓Primary knee osteoarthritis
Key exclusion· 8
  • ✕Inability to walk
  • ✕Severe joint instability
  • ✕History of previous shortwave diathermy
  • ✕Intra-articular injection within 3 months

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00199914
NCT00199914Phase 3Completed
CompareCT.gov

The Effectiveness of Shortwave Diathermy in Knee Osteoarthritis: A Randomized Controlled Trial

Mahidol University·interventional·Posted Sep 20, 2005·Updated Oct 14, 2022

In Brief

A Phase 3 clinical trial evaluating Shortwave diathermy for Osteoarthritis, Knee and Menopause. Completed, enrolled 113 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether shortwave diathermy is effective in reducing knee pain and increasing function of the patients with knee osteoarthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee, Menopause
CountriesThailand
Collaborators--

Timeline

Phase 3CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 20, 2005
Enrollment StartJan 1, 2004
Primary CompletionMay 1, 2004
Study CompletionJun 1, 2004
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 20.8 years ago

Interventions

Shortwave diathermydevice

continuous shortwave diathermy, 20 min/session, 3 sessions/week for 3 weeks